News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
559,715 Results
Type
Article (48230)
Company Profile (122)
Press Release (511363)
Multimedia
Podcasts (108)
Webinars (16)
Section
Business (151999)
Career Advice (2486)
Deals (28878)
Drug Delivery (122)
Drug Development (69888)
Employer Resources (158)
FDA (15935)
Job Trends (12420)
News (274295)
Policy (30395)
Tag
Academia (2520)
Academic (1)
Accelerated approval (14)
Adcomms (33)
Allergies (99)
Alliances (37706)
ALS (110)
Alzheimer's disease (1543)
Antibody-drug conjugate (ADC) (166)
Approvals (15879)
Artificial intelligence (317)
Autoimmune disease (36)
Automation (16)
Bankruptcy (315)
Best Places to Work (9499)
BIOSECURE Act (22)
Biosimilars (132)
Biotechnology (70)
Bladder cancer (98)
Brain cancer (35)
Breast cancer (354)
Cancer (2848)
Cardiovascular disease (239)
Career advice (2089)
Career pathing (33)
CAR-T (185)
CDC (43)
Cell therapy (507)
Cervical cancer (23)
Clinical research (57759)
Collaboration (931)
Company closure (3)
Compensation (711)
Complete response letters (38)
COVID-19 (2667)
CRISPR (61)
C-suite (337)
Cystic fibrosis (112)
Data (2963)
Decentralized trials (2)
Denatured (26)
Depression (79)
Diabetes (341)
Diagnostics (5534)
Digital health (20)
Diversity (5)
Diversity, equity & inclusion (43)
Drug discovery (128)
Drug pricing (151)
Drug shortages (33)
Duchenne muscular dystrophy (155)
Earnings (61093)
Editorial (50)
Employer branding (21)
Employer resources (142)
Events (82164)
Executive appointments (800)
FDA (17700)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (842)
Gene editing (132)
Generative AI (26)
Gene therapy (414)
GLP-1 (877)
Government (4121)
Grass and pollen (7)
Guidances (213)
Healthcare (15677)
HIV (40)
Huntington's disease (31)
IgA nephropathy (42)
Immunology and inflammation (187)
Immuno-oncology (13)
Indications (35)
Infectious disease (2852)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (66)
Intellectual property (115)
Interviews (463)
IPO (14346)
IRA (54)
Job creations (3262)
Job search strategy (1730)
Kidney cancer (14)
Labor market (50)
Layoffs (561)
Leadership (26)
Legal (7122)
Liver cancer (77)
Longevity (10)
Lung cancer (399)
Lymphoma (209)
Machine learning (12)
Management (54)
Manufacturing (404)
MASH (99)
Medical device (11560)
Medtech (11564)
Mergers & acquisitions (15231)
Metabolic disorders (897)
Multiple sclerosis (93)
NASH (22)
Neurodegenerative disease (144)
Neuropsychiatric disorders (45)
Neuroscience (2251)
NextGen: Class of 2025 (5271)
Non-profit (3471)
Now hiring (25)
Obesity (471)
Opinion (239)
Ovarian cancer (94)
Pain (114)
Pancreatic cancer (121)
Parkinson's disease (188)
Partnered (18)
Patents (313)
Patient recruitment (169)
Peanut (49)
People (46639)
Pharmaceutical (34)
Pharmacy benefit managers (25)
Phase I (17240)
Phase II (24993)
Phase III (20423)
Pipeline (1687)
Policy (246)
Postmarket research (2357)
Preclinical (7078)
Press Release (42)
Prostate cancer (149)
Psychedelics (43)
Radiopharmaceuticals (226)
Rare diseases (510)
Real estate (4505)
Recruiting (63)
Regulatory (21893)
Reports (36)
Research institute (2151)
Resumes & cover letters (411)
Rett syndrome (9)
RNA editing (9)
RSV (57)
Schizophrenia (99)
Series A (149)
Series B (104)
Service/supplier (9)
Sickle cell disease (66)
Special edition (20)
Spinal muscular atrophy (132)
Sponsored (36)
Startups (2884)
State (1)
Stomach cancer (17)
Supply chain (80)
Tariffs (71)
The Weekly (81)
Vaccines (894)
Venture capital (59)
Weight loss (322)
Women's health (41)
Worklife (20)
Date
Today (94)
Last 7 days (507)
Last 30 days (1709)
Last 365 days (29167)
2025 (17093)
2024 (31945)
2023 (35658)
2022 (45824)
2021 (49576)
2020 (46646)
2019 (37898)
2018 (28633)
2017 (28593)
2016 (26821)
2015 (29276)
2014 (22955)
2013 (18774)
2012 (20124)
2011 (20485)
2010 (18791)
Location
Africa (706)
Alabama (53)
Alaska (6)
Arizona (187)
Arkansas (10)
Asia (32447)
Australia (5694)
California (7073)
Canada (1913)
China (562)
Colorado (288)
Connecticut (317)
Delaware (181)
Europe (83306)
Florida (1096)
Georgia (232)
Hawaii (3)
Idaho (39)
Illinois (561)
India (28)
Indiana (298)
Iowa (18)
Japan (219)
Kansas (94)
Kentucky (21)
Louisiana (14)
Maine (64)
Maryland (998)
Massachusetts (5295)
Michigan (211)
Minnesota (403)
Mississippi (3)
Missouri (87)
Montana (13)
Nebraska (19)
Nevada (76)
New Hampshire (56)
New Jersey (2008)
New Mexico (18)
New York (1942)
North Carolina (1035)
North Dakota (8)
Northern California (3182)
Ohio (197)
Oklahoma (10)
Oregon (28)
Pennsylvania (1511)
Puerto Rico (11)
Rhode Island (24)
South America (1066)
South Carolina (33)
South Dakota (1)
Southern California (2670)
Tennessee (113)
Texas (1025)
United States (25913)
Utah (179)
Virginia (184)
Washington D.C. (69)
Washington State (587)
West Virginia (4)
Wisconsin (73)
559,715 Results for "king s college london".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London
May 15, 2025
·
6 min read
Business
Recursion Announces Plans to Open New Office in London
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced plans to open a new office in London’s vibrant King’s Cross neighborhood.
March 11, 2024
·
6 min read
Business
Apollo Therapeutics and King’s College London Enter Into a Strategic Collaboration
Apollo Therapeutics, a biopharmaceutical company focused on translational biology and asset-centric drug development, and King’s College London, announced the formation of a new strategic collaboration.
February 22, 2022
·
3 min read
Press Releases
DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee
June 9, 2025
·
2 min read
Press Releases
David P. King Joins Truvian’s Advisory Board
January 13, 2025
·
2 min read
Press Releases
Niagen Bioscience to Participate at the Roth 15th Annual London Conference
June 23, 2025
·
2 min read
Press Releases
Agilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London Scientists
January 13, 2025
·
4 min read
Press Releases
Breakthrough AI Model Maps Hidden Genetic Connections Among Global Populations Through Self-Discovery
Ecotone’s Seq2KING Uses Pioneering “Neural Excavation” to Map Human Heritage Patterns, Advancing Precision Medicine Development
July 23, 2025
·
1 min read
BioMidwest
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
ENDRA Life Sciences Inc., a pioneer of enhanced ultrasound technologies, announced that King’s College Hospital, London is now partnering with ENDRA for a clinical study of ENDRA’s Thermo-Acoustic Enhanced Ultrasound device for assessing Non-Alcoholic Fatty Liver Disease.
December 13, 2021
·
6 min read
Biotech Beach
NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to Date
NeuroSigma, Inc., a bioelectronic medical device company, today announced that a team at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London received approval from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) to commence the largest trial of external Trigeminal Nerve Stimulation (eTNS) ever conducted.
April 7, 2022
·
6 min read
1 of 55,972
Next
